RAC 0.57% $1.75 race oncology ltd

Ann: Race releases cardioprotection market potential data, page-81

  1. 8,391 Posts.
    lightbulb Created with Sketch. 1383
    Hi @Mason14

    Thanks for dropping in to HC.

    I wouldn't underestimate the technical ability of the market research company. They specialise in bio market research.

    As to why there were no questions on FTO, I can think of several reasons:
    * this study was mainly about cardioprotection
    * it isn't necessary to discuss a drug's MOA in order to estimate potential revenues. Patient numbers and price are enough.
    * the oncologist respondents may not be up as to speed on FTO as RAC shareholders are, and we didn't want to embarrass them.
    Last edited by IndexInvestor: 04/04/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.75
Change
0.010(0.57%)
Mkt cap ! $298.0M
Open High Low Value Volume
$1.73 $1.83 $1.73 $272.0K 152.3K

Buyers (Bids)

No. Vol. Price($)
1 9998 $1.75
 

Sellers (Offers)

Price($) Vol. No.
$1.79 2000 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.